Bausch Health Companies Inc

NYSE:BHC  
28.86
-0.61 (-2.07%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)10.14B
Current PEN/A
Forward PE 6.87
2yr Forward PE 6.08
See more stats
Estimates Current Quarter
Revenue$2.15 Billion
Adjusted EPS$1.06
See more estimates
10-Day MA$28.38
50-Day MA$28.18
200-Day MA$28.64
See more pivots

Bausch Health Companies Inc Stock, NYSE:BHC

2150 St. Elz?©ar Boulevard West, Laval, Qu?©bec H7L 4A8
United States of America
Phone: +1.514.744.6792
Number of Employees: 21600

Description

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Salix segment consists of sales in the U.S. of GI products. The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.